Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
29 October 2021Website:
http://www.aurabiosciences.comNext earnings report:
09 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | 10 min agoDividend
Analysts recommendations
Institutional Ownership
What type of business is Aura Biosciences?
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, including choroidal metastases. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.
What sector is Aura Biosciences in?
Aura Biosciences is in the Healthcare sector
What industry is Aura Biosciences in?
Aura Biosciences is in the Biotechnology industry
What country is Aura Biosciences from?
Aura Biosciences is headquartered in United States
When did Aura Biosciences go public?
Aura Biosciences initial public offering (IPO) was on 29 October 2021
What is Aura Biosciences website?
https://www.aurabiosciences.com
Is Aura Biosciences in the S&P 500?
No, Aura Biosciences is not included in the S&P 500 index
Is Aura Biosciences in the NASDAQ 100?
No, Aura Biosciences is not included in the NASDAQ 100 index
Is Aura Biosciences in the Dow Jones?
No, Aura Biosciences is not included in the Dow Jones index
When does Aura Biosciences report earnings?
The next expected earnings date for Aura Biosciences is 09 August 2024